Yu M - Search Results

1

The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis.

Tuohy VK, Yu M, Yin L, Kawczak JA, Johnson JM, Mathisen PM, Weinstock-Guttman B, Kinkel RP. Tuohy VK, et al. Among authors: yu m. Immunol Rev. 1998 Aug;164:93-100. doi: 10.1111/j.1600-065x.1998.tb01211.x. Immunol Rev. 1998. PMID: 9795767 Review.

2

Interferon-beta inhibits progression of relapsing-remitting experimental autoimmune encephalomyelitis.

Yu M, Nishiyama A, Trapp BD, Tuohy VK. Yu M, et al. J Neuroimmunol. 1996 Jan;64(1):91-100. doi: 10.1016/0165-5728(95)00160-3. J Neuroimmunol. 1996. PMID: 8598395

3

A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease.

Yu M, Johnson JM, Tuohy VK. Yu M, et al. J Exp Med. 1996 Apr 1;183(4):1777-88. doi: 10.1084/jem.183.4.1777. J Exp Med. 1996. PMID: 8666934 Free PMC article.

4

Determinant-regulated onset of experimental autoimmune encephalomyelitis: distinct epitopes of myelin proteolipid protein mediate either acute or delayed disease in SJL/J mice.

Tuohy VK, Thomas DM, Haqqi T, Yu M, Johnson JM. Tuohy VK, et al. Among authors: yu m. Autoimmunity. 1995;21(3):203-14. doi: 10.3109/08916939509008017. Autoimmunity. 1995. PMID: 8822278

5

Generation of autonomously pathogenic neo-autoreactive Th1 cells during the development of the determinant spreading cascade in murine autoimmune encephalomyelitis.

Yu M, Johnson JM, Tuohy VK. Yu M, et al. J Neurosci Res. 1996 Aug 15;45(4):463-70. doi: 10.1002/(SICI)1097-4547(19960815)45:4<463::AID-JNR16>3.0.CO;2-1. J Neurosci Res. 1996. PMID: 8872907

6

Diversity and plasticity of self recognition during the development of multiple sclerosis.

Tuohy VK, Yu M, Weinstock-Guttman B, Kinkel RP. Tuohy VK, et al. Among authors: yu m. J Clin Invest. 1997 Apr 1;99(7):1682-90. doi: 10.1172/JCI119331. J Clin Invest. 1997. PMID: 9120012 Free PMC article.

7

Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells.

Mathisen PM, Yu M, Johnson JM, Drazba JA, Tuohy VK. Mathisen PM, et al. Among authors: yu m. J Exp Med. 1997 Jul 7;186(1):159-64. doi: 10.1084/jem.186.1.159. J Exp Med. 1997. PMID: 9207010 Free PMC article.

8

HLA-DP: a class II restriction molecule involved in epitope spreading during the development of multiple sclerosis.

Yu M, Kinkel RP, Weinstock-Guttman B, Cook DJ, Tuohy VK. Yu M, et al. Hum Immunol. 1998 Jan;59(1):15-24. doi: 10.1016/s0198-8859(97)00252-8. Hum Immunol. 1998. PMID: 9544235

9

In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis.

Rudick RA, Ransohoff RM, Lee JC, Peppler R, Yu M, Mathisen PM, Tuohy VK. Rudick RA, et al. Among authors: yu m. Neurology. 1998 May;50(5):1294-300. doi: 10.1212/wnl.50.5.1294. Neurology. 1998. PMID: 9595977 Clinical Trial.

10

Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis.

Tuohy VK, Yu M, Yin L, Kawczak JA, Kinkel RP. Tuohy VK, et al. Among authors: yu m. J Exp Med. 1999 Apr 5;189(7):1033-42. doi: 10.1084/jem.189.7.1033. J Exp Med. 1999. PMID: 10190894 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,541 results

Search Page

Filters